Issue 28 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

18

No.

28

July 10, 1992Jul 10, 1992

Free

DOWNLOAD THE PDF

DCT Advisors Approve $22 Mil. Set Aside For Interactive R01s Systemic Therapies

In Brief: NCI Awards 4 Contracts For Enrichment Program; Dana-Farber Names Breast Center Leadership

NIH Authorization Set For Another Try; Women’s Cancers Are Targeted

DCT Advisers Ok Expansion of Phase 1, Phase 2 Testing

More DCT Concepts Approved By Advisors

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

Procedures For Ending IGs Announced

Recent Issues

Volume 52 | Issue 16 - April 24, 2026

Volume 52 | Issue 15 - April 17, 2026

Volume 52 | Issue 14 - April 10, 2026

Volume 52 | Issue 13 - April 03, 2026

Volume 52 | Issue 12 - March 27, 2026

Volume 52 | Issue 11 - March 20, 2026